Related Experiment Videos

Pediatric respiratory diseases: 2011 update for the Rogers' Textbook of Pediatric Intensive Care

Kathleen M Ventre1, Gerhard K Wolf, John H Arnold

  • 1Section of Critical Care Medicine, The Children's Hospital, Denver, CO, USA.

Insights

Recent advancements in pediatric respiratory diseases offer new therapeutic strategies for conditions like viral-induced airway disease and neonatal respiratory failure. New monitoring techniques and imaging are guiding future research in acute lung injury.

Area of Science:

  • Pediatric Respiratory Medicine
  • Pediatric Intensive Care
  • Critical Care Medicine

Background:

  • Significant advancements in pediatric respiratory disease research have emerged since 2008.
  • Key areas include status asthmaticus, bronchiolitis, pneumonia, acute lung injury, and neonatal respiratory failure.
  • Understanding pathogenesis and management requires continuous literature review.

Purpose of the Study:

  • To review recent literature on pediatric respiratory diseases published after 2008.
  • To identify key developments impacting clinical practice and future research.
  • To synthesize findings across major pediatric respiratory conditions.

Main Methods:

  • Comprehensive literature search of PubMed and reference lists of key articles.
  • Inclusion of adult literature relevant to pediatric conditions.
  • Inquiry into ongoing clinical trials for acute lung injury via ClinicalTrials.gov.
  • Consideration of new publications in respiratory monitoring.

Main Results:

  • Selected articles cover status asthmaticus, bronchiolitis, pneumonia, acute lung injury/acute respiratory distress syndrome, respiratory monitoring, and neonatal respiratory failure.
  • New insights into respiratory syncytial virus (RSV) pathogenesis suggest novel therapies.
  • Computed tomography (CT) imaging during mechanical ventilation aids acute lung injury research.
  • Noninvasive support shows promise in modifying neonatal respiratory failure outcomes.

Conclusions:

  • Important developments in pathogenesis and management of pediatric respiratory diseases.
  • Potential for novel therapies for viral-induced airways disease.
  • CT imaging and advanced monitoring techniques facilitate future acute lung injury research.
  • Noninvasive support strategies can improve neonatal respiratory failure management.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: